KHB Shanghai Kehua Bio-Engineering Acquires the Italian Technogenetics PR Newswire MILAN, December 21, 2015 MILAN , December 21, 2015 /PRNewswire/ — KHB Shanghai Kehua Bio-Engineering Co., Ltd listed on the Shenzhen Stock Exchange (Stock Code 002022), one of the leading in vitro diagnostic (IVD) products developers in China , announced today the closure of the deal with Technogenetics, innovative immunodiagnostics Italian company, that concerns the acquisition of the Italian company and of the IVD assets of Altergon Italia, a manufacturing and innovative pharmaceutical formulations developer. Under the terms of the agreement KHB Shanghai Kehua Bio-Engineering Co has acquired 100% of Technogenetics with an investment of 28.8 million Euro , 18.8 used for the acquisition and the rest 10 million Euro for the business development in the following 18 months. An Italian New Co, called Technogenetics Holdings, has been created by the integration of the innovative immunodiagnostics research mission of Technogenetics with a 30 years proved IVD manufacturing experience of KHB Shanghai Kehua Bio-Engineering Co […]